Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Understanding cognitive functioning in glioma patients: The relevance of IDH-mutation status and functional connectivity.

Derks J, Kulik S, Wesseling P, Numan T, Hillebrand A, van Dellen E, de Witt Hamer PC, Geurts JJG, Reijneveld JC, Stam CJ, Klein M, Douw L.

Brain Behav. 2019 Feb 26:e01204. doi: 10.1002/brb3.1204. [Epub ahead of print]

2.

Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach.

Jonkman LE, Kenkhuis B, Geurts JJG, van de Berg WDJ.

Neurosci Bull. 2019 Apr;35(2):229-243. doi: 10.1007/s12264-019-00342-3. Epub 2019 Feb 21. Review.

PMID:
30790214
3.

Normal Aging Brain Collection Amsterdam (NABCA): A comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls.

Jonkman LE, Graaf YG, Bulk M, Kaaij E, Pouwels PJW, Barkhof F, Rozemuller AJM, van der Weerd L, Geurts JJG, van de Berg WDJ.

Neuroimage Clin. 2019 Jan 29;22:101698. doi: 10.1016/j.nicl.2019.101698. [Epub ahead of print]

4.

Association between pathological and MRI findings in multiple sclerosis.

Filippi M, Brück W, Chard D, Fazekas F, Geurts JJG, Enzinger C, Hametner S, Kuhlmann T, Preziosa P, Rovira À, Schmierer K, Stadelmann C, Rocca MA; Attendees of the Correlation between Pathological and MRI findings in MS workshop.

Lancet Neurol. 2019 Feb;18(2):198-210. doi: 10.1016/S1474-4422(18)30451-4. Review.

PMID:
30663609
5.

7T MRI allows detection of disturbed cortical lamination of the medial temporal lobe in patients with Alzheimer's disease.

Kenkhuis B, Jonkman LE, Bulk M, Buijs M, Boon BDC, Bouwman FH, Geurts JJG, van de Berg WDJ, van der Weerd L.

Neuroimage Clin. 2019;21:101665. doi: 10.1016/j.nicl.2019.101665. Epub 2019 Jan 5.

6.

Predicting clinical progression in multiple sclerosis after 6 and 12 years.

Dekker I, Eijlers AJC, Popescu V, Balk LJ, Vrenken H, Wattjes MP, Uitdehaag BMJ, Killestein J, Geurts JJG, Barkhof F, Schoonheim MM.

Eur J Neurol. 2019 Jan 10. doi: 10.1111/ene.13904. [Epub ahead of print]

PMID:
30629788
7.

What Causes Deep Gray Matter Atrophy in Multiple Sclerosis?

Schoonheim MM, Geurts JJG.

AJNR Am J Neuroradiol. 2019 Jan;40(1):107-108. doi: 10.3174/ajnr.A5942. Epub 2018 Dec 27. No abstract available.

PMID:
30591510
8.

Structural network topology relates to tissue properties in multiple sclerosis.

Kiljan S, Meijer KA, Steenwijk MD, Pouwels PJW, Schoonheim MM, Schenk GJ, Geurts JJG, Douw L.

J Neurol. 2019 Jan;266(1):212-222. doi: 10.1007/s00415-018-9130-2. Epub 2018 Nov 22.

9.

Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS.

Schoonhoven DN, Fraschini M, Tewarie P, Uitdehaag BM, Eijlers AJ, Geurts JJ, Hillebrand A, Schoonheim MM, Stam CJ, Strijbis EM.

Mult Scler. 2018 Nov 22:1352458518810260. doi: 10.1177/1352458518810260. [Epub ahead of print]

PMID:
30465461
10.

2018 Editors' commentary.

Thompson A, Antel J, Carroll WM, Geurts JJ.

Mult Scler. 2018 Oct;24(11):1394-1395. doi: 10.1177/1352458518801764. No abstract available.

PMID:
30289380
11.

Is impaired information processing speed a matter of structural or functional damage in MS?

Meijer KA, van Geest Q, Eijlers AJC, Geurts JJG, Schoonheim MM, Hulst HE.

Neuroimage Clin. 2018;20:844-850. doi: 10.1016/j.nicl.2018.09.021. Epub 2018 Sep 26.

12.

The hippocampus in multiple sclerosis.

Rocca MA, Barkhof F, De Luca J, Frisén J, Geurts JJG, Hulst HE, Sastre-Garriga J, Filippi M; MAGNIMS Study Group.

Lancet Neurol. 2018 Oct;17(10):918-926. doi: 10.1016/S1474-4422(18)30309-0. Epub 2018 Sep 18. Review.

PMID:
30264730
13.

Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.

Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, Barkhof F, Uitdehaag BMJ, Schoonheim MM, Geurts JJG.

Brain. 2018 Sep 1;141(9):2605-2618. doi: 10.1093/brain/awy202.

PMID:
30169585
14.

Comparison of a Novel Cadaver Model (Fix for Life) With the Formalin-Fixed Cadaver and Manikin Model for Suitability and Realism in Airway Management Training.

van Emden MW, Geurts JJ, Schober P, Schwarte LA.

Anesth Analg. 2018 Oct;127(4):914-919. doi: 10.1213/ANE.0000000000003678.

15.

Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma.

Derks J, Wesseling P, Carbo EWS, Hillebrand A, van Dellen E, de Witt Hamer PC, Klein M, Schenk GJ, Geurts JJG, Reijneveld JC, Douw L.

J Neurooncol. 2018 Nov;140(2):403-412. doi: 10.1007/s11060-018-2967-5. Epub 2018 Aug 9.

16.

Information processing speed in multiple sclerosis: Relevance of default mode network dynamics.

van Geest Q, Douw L, van 't Klooster S, Leurs CE, Genova HM, Wylie GR, Steenwijk MD, Killestein J, Geurts JJG, Hulst HE.

Neuroimage Clin. 2018 May 15;19:507-515. doi: 10.1016/j.nicl.2018.05.015. eCollection 2018.

17.

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group.

Neuroimage Clin. 2018 Apr 26;19:466-475. doi: 10.1016/j.nicl.2018.04.023. eCollection 2018. Review.

18.

Thinking about the nerve impulse: A critical analysis of the electricity-centered conception of nerve excitability.

Drukarch B, Holland HA, Velichkov M, Geurts JJG, Voorn P, Glas G, de Regt HW.

Prog Neurobiol. 2018 Oct;169:172-185. doi: 10.1016/j.pneurobio.2018.06.009. Epub 2018 Jul 4. Review.

19.

Determinants of Cognitive Impairment in Patients with Multiple Sclerosis with and without Atrophy.

Eijlers AJC, Meijer KA, van Geest Q, Geurts JJG, Schoonheim MM.

Radiology. 2018 Aug;288(2):544-551. doi: 10.1148/radiol.2018172808. Epub 2018 May 22.

PMID:
29786489
20.

The importance of hippocampal dynamic connectivity in explaining memory function in multiple sclerosis.

van Geest Q, Hulst HE, Meijer KA, Hoyng L, Geurts JJG, Douw L.

Brain Behav. 2018 Mar 30;8(5):e00954. doi: 10.1002/brb3.954. eCollection 2018 May.

21.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

22.

A discrete polar Stockwell transform for enhanced characterization of tissue structure using MRI.

Pridham G, Steenwijk MD, Geurts JJG, Zhang Y.

Magn Reson Med. 2018 Dec;80(6):2731-2743. doi: 10.1002/mrm.27219. Epub 2018 May 2.

PMID:
29722063
23.

Lipid biochemical changes detected in normal appearing white matter of chronic multiple sclerosis by spectral coherent Raman imaging.

Poon KWC, Brideau C, Klaver R, Schenk GJ, Geurts JJ, Stys PK.

Chem Sci. 2018 Jan 2;9(6):1586-1595. doi: 10.1039/c7sc03992a. eCollection 2018 Feb 14.

24.

Fronto-limbic disconnection in patients with multiple sclerosis and depression.

van Geest Q, Boeschoten RE, Keijzer MJ, Steenwijk MD, Pouwels PJ, Twisk JW, Smit JH, Uitdehaag BM, Geurts JJ, van Oppen P, Hulst HE.

Mult Scler. 2018 Mar 1:1352458518767051. doi: 10.1177/1352458518767051. [Epub ahead of print]

PMID:
29587565
25.

Postmortem magnetic resonance imaging.

Jonkman LE, Geurts JJG.

Handb Clin Neurol. 2018;150:335-354. doi: 10.1016/B978-0-444-63639-3.00023-2.

PMID:
29496152
26.

Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study.

Tewarie P, Steenwijk MD, Brookes MJ, Uitdehaag BMJ, Geurts JJG, Stam CJ, Schoonheim MM.

Hum Brain Mapp. 2018 Jun;39(6):2541-2548. doi: 10.1002/hbm.24020. Epub 2018 Feb 21.

27.

Cognition in multiple sclerosis: State of the field and priorities for the future.

Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P, Hulst H, Inglese M, Leavitt VM, Rocca MA, Rosti-Otajarvi EM, Rao S.

Neurology. 2018 Feb 6;90(6):278-288. doi: 10.1212/WNL.0000000000004977. Epub 2018 Jan 17. Review.

28.

Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward.

Benedict RHB, DeLuca J, Enzinger C, Geurts JJG, Krupp LB, Rao SM.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):832-842. doi: 10.1017/S1355617717000959. Review.

PMID:
29198279
29.

9.4T and 17.6T MRI of Retinoblastoma: Ex Vivo evaluation of microstructural anatomy and disease extent compared with histopathology.

de Jong MC, de Graaf P, Pouwels PJW, Beenakker JW, Jansen RW, Geurts JJG, Moll AC, Castelijns JA, van der Valk P, van der Weerd L.

J Magn Reson Imaging. 2018 Jun;47(6):1487-1497. doi: 10.1002/jmri.25913. Epub 2017 Nov 28.

PMID:
29193569
30.

Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): a study protocol for a randomised controlled trial.

Nauta IM, Speckens AEM, Kessels RPC, Geurts JJG, de Groot V, Uitdehaag BMJ, Fasotti L, de Jong BA.

BMC Neurol. 2017 Nov 21;17(1):201. doi: 10.1186/s12883-017-0979-y.

31.

Asymptomatic spinal cord lesions do not predict the time to disability in patients with early multiple sclerosis.

Dekker I, Sombekke MH, Witte BI, Geurts JJ, Barkhof F, Uitdehaag BM, Killestein J, Wattjes MP.

Mult Scler. 2018 Apr;24(4):481-490. doi: 10.1177/1352458517736147. Epub 2017 Nov 6. Erratum in: Mult Scler. 2019 Jan;25(1):NP2.

32.

Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.

Meijer KA, Eijlers AJC, Geurts JJG, Schoonheim MM.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):205-210. doi: 10.1136/jnnp-2017-316329. Epub 2017 Oct 6.

PMID:
28986469
33.

Cognitive impairment and the regional distribution of cerebellar lesions in multiple sclerosis.

Tobyne SM, Ochoa WB, Bireley JD, Smith VM, Geurts JJ, Schmahmann JD, Klawiter EC.

Mult Scler. 2018 Nov;24(13):1687-1695. doi: 10.1177/1352458517730132. Epub 2017 Sep 21.

PMID:
28933672
34.

Cortical pathology in multiple sclerosis detected by the T1/T2-weighted ratio from routine magnetic resonance imaging.

Righart R, Biberacher V, Jonkman LE, Klaver R, Schmidt P, Buck D, Berthele A, Kirschke JS, Zimmer C, Hemmer B, Geurts JJG, Mühlau M.

Ann Neurol. 2017 Oct;82(4):519-529. doi: 10.1002/ana.25020. Epub 2017 Sep 16.

35.

Cortical Remyelination Is Heterogeneous in Multiple Sclerosis.

Strijbis EMM, Kooi EJ, van der Valk P, Geurts JJG.

J Neuropathol Exp Neurol. 2017 May 1;76(5):390-401. doi: 10.1093/jnen/nlx023.

PMID:
28521040
36.

Increased connectivity of hub networks and cognitive impairment in multiple sclerosis.

Meijer KA, Eijlers AJC, Douw L, Uitdehaag BMJ, Barkhof F, Geurts JJG, Schoonheim MM.

Neurology. 2017 May 30;88(22):2107-2114. doi: 10.1212/WNL.0000000000003982. Epub 2017 May 3.

PMID:
28468841
37.

Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis.

Klauser AM, Wiebenga OT, Eijlers AJ, Schoonheim MM, Uitdehaag BM, Barkhof F, Pouwels PJ, Geurts JJ.

Mult Scler. 2018 Apr;24(4):491-500. doi: 10.1177/1352458517702534. Epub 2017 Apr 13.

PMID:
28406063
38.

The measure tells the tale: Clinical outcome measures in multiple sclerosis.

Hulst HE, Thompson AJ, Geurts JJ.

Mult Scler. 2017 Apr;23(5):626-627. doi: 10.1177/1352458517690825. Epub 2017 Feb 16. No abstract available.

PMID:
28206813
39.

Increased default-mode network centrality in cognitively impaired multiple sclerosis patients.

Eijlers AJ, Meijer KA, Wassenaar TM, Steenwijk MD, Uitdehaag BM, Barkhof F, Wink AM, Geurts JJ, Schoonheim MM.

Neurology. 2017 Mar 7;88(10):952-960. doi: 10.1212/WNL.0000000000003689. Epub 2017 Feb 8.

PMID:
28179464
40.

Dynamic hub load predicts cognitive decline after resective neurosurgery.

Carbo EW, Hillebrand A, van Dellen E, Tewarie P, de Witt Hamer PC, Baayen JC, Klein M, Geurts JJ, Reijneveld JC, Stam CJ, Douw L.

Sci Rep. 2017 Feb 7;7:42117. doi: 10.1038/srep42117.

41.

Connectomic profile and clinical phenotype in newly diagnosed glioma patients.

Derks J, Dirkson AR, de Witt Hamer PC, van Geest Q, Hulst HE, Barkhof F, Pouwels PJ, Geurts JJ, Reijneveld JC, Douw L.

Neuroimage Clin. 2017 Jan 16;14:87-96. doi: 10.1016/j.nicl.2017.01.007. eCollection 2017.

42.

Brain MRI atrophy quantification in MS: From methods to clinical application.

Rocca MA, Battaglini M, Benedict RH, De Stefano N, Geurts JJ, Henry RG, Horsfield MA, Jenkinson M, Pagani E, Filippi M.

Neurology. 2017 Jan 24;88(4):403-413. doi: 10.1212/WNL.0000000000003542. Epub 2016 Dec 16. Review.

43.

rTMS affects working memory performance, brain activation and functional connectivity in patients with multiple sclerosis.

Hulst HE, Goldschmidt T, Nitsche MA, de Wit SJ, van den Heuvel OA, Barkhof F, Paulus W, van der Werf YD, Geurts JJG.

J Neurol Neurosurg Psychiatry. 2017 May;88(5):386-394. doi: 10.1136/jnnp-2016-314224. Epub 2016 Dec 14.

PMID:
27974394
44.

Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis.

Michailidou I, Naessens DM, Hametner S, Guldenaar W, Kooi EJ, Geurts JJ, Baas F, Lassmann H, Ramaglia V.

Glia. 2017 Feb;65(2):264-277. doi: 10.1002/glia.23090. Epub 2016 Oct 25.

45.

The role of sleep on cognition and functional connectivity in patients with multiple sclerosis.

van Geest Q, Westerik B, van der Werf YD, Geurts JJ, Hulst HE.

J Neurol. 2017 Jan;264(1):72-80. doi: 10.1007/s00415-016-8318-6. Epub 2016 Oct 24.

46.

Visualization of cortical MS lesions with MRI need not be further improved - YES.

Geurts JJ, Chard DT.

Mult Scler. 2017 Jan;23(1):15-17. doi: 10.1177/1352458516665498. Epub 2016 Sep 28. No abstract available.

PMID:
27566450
47.

Patterns of white matter damage are non-random and associated with cognitive function in secondary progressive multiple sclerosis.

Meijer KA, Cercignani M, Muhlert N, Sethi V, Chard D, Geurts JJ, Ciccarelli O.

Neuroimage Clin. 2016 Jun 14;12:123-31. doi: 10.1016/j.nicl.2016.06.009. eCollection 2016.

48.

Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.

Shakhbazau A, Schenk GJ, Hay C, Kawasoe J, Klaver R, Yong VW, Geurts JJ, van Minnen J.

Mol Biol Rep. 2016 Jun;43(6):495-507. doi: 10.1007/s11033-016-3990-2. Epub 2016 Apr 26.

PMID:
27115494
49.

White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.

Wiebenga OT, Schoonheim MM, Hulst HE, Nagtegaal GJ, Strijbis EM, Steenwijk MD, Polman CH, Pouwels PJ, Barkhof F, Geurts JJ.

AJNR Am J Neuroradiol. 2016 Jun;37(6):1030-7. doi: 10.3174/ajnr.A4690. Epub 2016 Mar 10.

50.

Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.

Kilsdonk ID, Jonkman LE, Klaver R, van Veluw SJ, Zwanenburg JJ, Kuijer JP, Pouwels PJ, Twisk JW, Wattjes MP, Luijten PR, Barkhof F, Geurts JJ.

Brain. 2016 May;139(Pt 5):1472-81. doi: 10.1093/brain/aww037. Epub 2016 Mar 8.

PMID:
26956422

Supplemental Content

Loading ...
Support Center